ONOFRJ, Marco
 Distribuzione geografica
Continente #
NA - Nord America 23.528
EU - Europa 16.548
AS - Asia 14.913
SA - Sud America 2.156
AF - Africa 266
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 37
Totale 57.491
Nazione #
US - Stati Uniti d'America 23.061
SG - Singapore 6.155
CN - Cina 4.048
IT - Italia 3.214
RU - Federazione Russa 2.468
IE - Irlanda 2.224
UA - Ucraina 2.119
BR - Brasile 1.741
GB - Regno Unito 1.536
TR - Turchia 1.449
VN - Vietnam 1.372
SE - Svezia 1.364
DE - Germania 1.267
FR - Francia 974
IN - India 660
FI - Finlandia 586
HK - Hong Kong 299
CA - Canada 264
BD - Bangladesh 233
AR - Argentina 154
MX - Messico 146
NL - Olanda 126
JP - Giappone 122
ZA - Sudafrica 116
PL - Polonia 111
AT - Austria 110
ES - Italia 99
IQ - Iraq 88
CZ - Repubblica Ceca 68
BE - Belgio 66
EC - Ecuador 65
ID - Indonesia 60
PK - Pakistan 52
CO - Colombia 49
KR - Corea 49
VE - Venezuela 44
MA - Marocco 39
UZ - Uzbekistan 37
IR - Iran 35
CH - Svizzera 33
LT - Lituania 33
EU - Europa 31
SA - Arabia Saudita 31
CL - Cile 30
AE - Emirati Arabi Uniti 28
LU - Lussemburgo 28
AU - Australia 27
EG - Egitto 26
IL - Israele 25
PH - Filippine 22
PY - Paraguay 22
PE - Perù 21
JO - Giordania 19
RO - Romania 18
TN - Tunisia 18
MY - Malesia 17
JM - Giamaica 16
PT - Portogallo 15
AZ - Azerbaigian 14
NZ - Nuova Zelanda 14
UY - Uruguay 14
DZ - Algeria 13
KE - Kenya 13
GR - Grecia 12
OM - Oman 12
HN - Honduras 11
BG - Bulgaria 10
DK - Danimarca 10
KG - Kirghizistan 10
NP - Nepal 10
BO - Bolivia 9
SN - Senegal 9
AL - Albania 8
AO - Angola 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
KZ - Kazakistan 8
LB - Libano 8
NO - Norvegia 8
CR - Costa Rica 7
HU - Ungheria 7
HR - Croazia 6
RS - Serbia 6
TW - Taiwan 6
AM - Armenia 5
LV - Lettonia 5
PA - Panama 5
GE - Georgia 4
GY - Guiana 4
NG - Nigeria 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
BH - Bahrain 3
CY - Cipro 3
GH - Ghana 3
KH - Cambogia 3
LK - Sri Lanka 3
SI - Slovenia 3
Totale 57.440
Città #
Singapore 4.467
San Jose 2.932
Chandler 2.662
Jacksonville 2.443
Dublin 2.188
Ashburn 1.641
Princeton 1.060
Dallas 1.038
Beijing 986
Southend 965
Izmir 752
Nanjing 684
Los Angeles 607
Council Bluffs 573
Wilmington 517
Santa Clara 467
Ho Chi Minh City 449
Munich 421
The Dalles 415
Dearborn 412
New York 395
Cambridge 377
Altamura 373
Chieti 320
Ann Arbor 312
Hanoi 285
Tongling 284
Buffalo 282
Hong Kong 255
Nanchang 241
Boardman 220
Moscow 207
São Paulo 196
Woodbridge 195
Rome 176
Redondo Beach 151
Houston 149
Milan 149
Pescara 139
Orem 135
Shenyang 129
Helsinki 124
Hebei 123
Tianjin 112
Montreal 101
Washington 98
Tokyo 96
Jiaxing 93
London 92
Kunming 91
Turku 90
Brooklyn 89
Chennai 89
Hefei 89
Warsaw 89
Grevenbroich 86
Toronto 79
Norwalk 77
Atlanta 74
Falls Church 74
Denver 73
Frankfurt am Main 69
Hangzhou 68
Chicago 67
Da Nang 66
Changsha 63
Nuremberg 63
Manchester 61
Stockholm 61
Johannesburg 60
Seattle 58
Vienna 58
Phoenix 57
Haiphong 56
Brussels 55
Jinan 55
Rio de Janeiro 55
Poplar 53
Amsterdam 52
Dong Ket 52
Mexico City 52
Brno 45
Belo Horizonte 44
Lanzhou 42
San Francisco 42
Boston 41
Baghdad 40
Mumbai 40
Seoul 40
Charlotte 33
Tashkent 33
Florence 32
Guangzhou 32
Ningbo 32
Biên Hòa 31
Brasília 30
Leawood 30
Naples 30
Taizhou 30
New Delhi 29
Totale 34.345
Nome #
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 1.153
Emergenza neurologica - tempesta distonica: diagnosi e terapia 499
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 355
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 315
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 282
REGIONE ABRUZZO. POTENZIAMENTO DELLA DIAGNOSI PRECOCE DEL DISTURBO NEUROCOGNITIVO MINORE TRAMITE IMPLEMENTAZIONE DI UN MINIMUM DATASET E DI TECNICHE DI INTELLIGENZA ARTIFICIALE 223
Pre-trattamento antiematico per Test/terapia all'apomorfina 199
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 198
Ambiguity resolution in relative clauses: An ERPs study. 192
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 188
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 187
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 185
The Characterization of Regulatory T-Cell Profiles in Alzheimer’s Disease and Multiple Sclerosis 184
Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis 182
GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images 181
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 179
null 178
"CADASIL coma" in an Italian homozygous CADASIL patient: comparison with clinical and MRI findings in age-matched heterozygous patients with the same G528C NOTCH3 mutation 178
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 176
GABA content within the ventro-medial prefrontal cortex is related to trait anxiety 172
Ambiguity resolution and working memory span effects: An ERPs study 170
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 168
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 168
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 167
Akinetic crisis in Dementia with Lewy Bodies 167
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 166
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 163
Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing 163
Specializzazione funzionale della corteccia visiva nell'uomo. Studio con risonanza magnetica funzionale e potenziali evocati visivi 161
Atrophy of hippocampal subfields and amygdala nuclei in subjects with mild cognitive impairment progressing to Alzheimer's disease 160
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 160
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 159
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 159
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 158
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 157
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 156
Noun animacy and ERP components modulation 155
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 155
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 155
A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum 154
Fisiopatologia dei ritardi di conduzione nella sclerosi multipla 152
ALZHEIMER DISEASE AND LEWY BODY DEMENTIA CAN BE DISTINGUISHED BY THE CYTOMETRIC IDENTIFICATION OF A NOVEL DIAGNOSTIC BIOMARKER 152
Asymptomatic carotid acute dissection following focal status epilepticus. 152
Functional specialization in human visual cortex: Evaluation by visual evoked potentials and fMRI 151
Progetto atrofia multisistemica: risultati preliminari. 151
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 151
A combined EEG MEG fMRI study of the cortical activaties following pattern reversal visual stimuli 150
Improving diagnostic accuracy of DLB: An MRI study 150
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 150
GABA content within medial prefrontal cortex predicts the variability of fronto-limbic effective connectivity 150
Bipallidal lesions induce delayed and progressive parkinsonism 149
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 149
Abnormal BAEP and internal auditory canal MRI in intracranial hypotension 149
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 149
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 149
Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder: A Pilot Study 148
BRAIN-STEM ACOUSTIC EVOKED-POTENTIALS (BAEPS) IN NEUROSURGICAL DISEASES 148
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 148
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 147
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 146
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 145
Attention network in AD and DLB patients: a resting fMRI study. 143
Tolcapone vs entacapone: efficacia ed effetti collaterali nel trattamento della sindrome di Parkinson 142
Autoscopic phenomena: case report and review of literature. 142
Monitoraggio in vivo, con Risonanza Magnetica Morfologica (MRI) e Spettroscopica (H-MRS), dei cambiamenti metabolici e morfologici sulla via nigro-striatale indotti dal trattamento con PSI in un modello animale di Parkinson 142
Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence 142
Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis 141
Amantadine for dyskinesia in patients affected by severe Parkinson's disease. 141
Cerebral mapping in patients with multifocal diffractive intraocular lens 141
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 141
Data of safety in a single-center alemtuzumab treated population 140
Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report 139
Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: A comparison with other clinical executive tasks. 138
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 138
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 137
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 137
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 137
Stormy onset of benign childhood epilepsy with occipital paroxysmal discharges 136
Instabilità posturale nel Parkinson non farmaco-responder 136
A stage-based approach to therapy in parkinson’s disease 136
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 135
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 135
Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease 135
Acute akinesia or akinetic crisis in Parkinson's disease. 134
Holmes-Like Tremor in Ataxia With Oculomotor Apraxia Type 2 134
Acting before; a combined strategy to counteract the onset and progression of dementia 134
Neuromagnetic responses reveal the cortical timing of audiovisual synchrony 133
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 132
Somatic symptoms disorders in Parkinson's disease are related to default mode and salience network dysfunction 132
A case of Sars-Cov-2-related mania with prominent psychosis> 132
Autoimmune encephalitis during pregnancy: a diagnostic and therapeutic challenge - A systematic review with individual patients' analysis and clinical recommendations 131
Echo long time STIR sequence magnetic resonance imaging of optic nerves in optic neuritis 131
A subtle mimicker in emergency department: Illustrated case reports of acute drug-induced dystonia 131
3D localization of interictal epileptic activity by neuromagnetic method 130
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 130
Home-based palliative approach for people with severe multiple sclerosis and their carers: Study protocol for a randomized controlled trial 130
L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain 129
Heat shock protein 70: implication for Alzheimer's disease 129
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 129
Atrofia Multisistemica: approccio diagnostico multidisciplinare 129
Totale 17.047
Categoria #
all - tutte 238.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 238.295


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021170 0 0 0 0 0 0 0 0 0 0 0 170
2021/20222.267 65 44 52 234 133 82 79 221 219 80 315 743
2022/20237.654 636 980 490 811 716 1.449 457 537 930 105 212 331
2023/20243.724 241 153 268 166 220 1.067 801 181 65 117 67 378
2024/20259.094 508 1.566 1.324 242 256 359 389 541 807 543 998 1.561
2025/202620.132 1.634 711 1.969 2.560 1.787 1.260 3.174 1.195 2.603 1.626 1.163 450
Totale 59.048